Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
TVTX logo

TVTX

NSD
Travere Therapeutics Inc.
ManufacturingPharmaceutical Preparation Manufacturing
Watchlists:
Last updated: Monday 14th July 2025
16.47
-0.08 (-0.48%)
Prev Close:16.55
Open:16.39
Bid:15.5
Ask:16.6
52 Week Range
7.93
25.29
Volume:1,595,451
Mkt Cap:1,359 M
Price Target
$18.94
+15.0%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
Financials

Financial Statements

TVTX - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Dec-15
Basic Discontinuous Operations-0.013.57
Depreciation And Amortization2 M2 M2 M2 M2 M700000.0-600000.0-500000.0-100000.0
Diluted Discontinuous Operations-0.013.57
Gain On Sale Of PPE900000.0
Gain On Sale Of Security0.0100000.0-300000.0
Gains Loss On Disposal Of Discontinued Operations-7 M
General And Administrative Expense264 M266 M198 M150 M136 M129 M80 M
Gross Profit Margin (profit Margin After CGS)225 M134 M105 M128 M192 M170 M147 M151 M129 M98 M
Impairment Of Capital Assets26 M5 M
Interest Expense Non Operating11 M11 M11 M20 M19 M19 M10 M4 M-800000.0-8 M
Misc Other Special Charges-3 M2 M-7 M231000.01 M-314000.0-18 M-3 M1 M8 M
Net Income (loss)-322 M-111 M-278 M-180 M-169 M-146 M-103 M-60 M-48 M117 M
Net Income Common Stockholders-322 M-111 M-278 M-180 M-169 M-152 M-103 M-60 M-48 M117 M
Net Income Continuous Operations-321 M-376 M-331 M-180 M-169 M-146 M-103 M-60 M-48 M117 M
Net Income Discontinuous Operations-915000.0265 M53 M-7 M
Net Non Operating Interest Income Expense7 M10 M5 M-18 M-14 M-9 M-4 M-4 M-759000.0-8 M
Net Operating Interest Income Expense5 M3 M
Non Recurring Operation Expense0.03 M5 M-15 M
Operating Income-324 M-388 M-320 M-162 M-176 M-137 M-80 M-28 M-34 M-32 M
Operating Income Before Depreciation (EBITDA)-264 M-325 M-298 M-184 M-145 M-98 M-70 M-34 M-40 M113 M
Operating Expense482 M511 M425 M360 M365 M270 M227 M-209 M-192 M130 M
Other Gain Loss From Disposition Of Discontinued Operations-915000.0265 M
Other Gand A264 M266 M198 M150 M136 M129 M80 M
Other Impairment Of Capital Assets15 M-5 M
Other Operating Expenses-2 M-1 M-235000.0-244 M-209 M-192 M-151 M
Research Expense217 M245 M227 M210 M229 M141 M124 M78 M71 M50 M
Restructring And Mn A Income2 M11 M-242000.04 M893000.0
Salaries And Wages-20 M-27 M-29 M
Selling And Marketing Expense104 M101 M92 M
Selling Expense104 M101 M92 M
Total Income Available For Interest Expense (EBIT)-309 M-365 M-320 M-197 M-170 M-128 M-92 M-54 M-58 M98 M
Total Revenues233 M145 M109 M227 M198 M175 M164 M155 M134 M100 M
Total Expenses489 M522 M429 M367 M371 M275 M222 M-212 M-196 M132 M
Total Revenue233 M145 M109 M132 M198 M175 M164 M155 M134 M100 M
Amord42 M36 M19 M25 M22 M20 M-18 M-19 M-16 M-13 M
Avgshs79 M74 M64 M60 M48 M42 M40 M39 M37 M34 M
Avgshsdt79 M74 M64 M60 M42 M40 M39 M38 M38 M
Basiceps-4.08-1.5-4.37-3.01-3.56-3.460.0-1.54-1.293.49
Basicepscont-4.07-5.07-4.37-3.01-3.56-3.463.49
Cor8 M11 M4 M4 M6 M5 M-6 M-4 M-5 M2 M
Depamor2 M2 M700000.0-600000.0-500000.0-100000.0
Dileps-4.08-1.5-4.37-3.01-3.56-3.46-2.54-1.54-1.293.17
Dilepscont-4.07-5.07-4.37-3.010.03.17
Intinc18 M22 M-5 M-18 M-14 M10 M5 M4 M-759000.0-8 M
Netincdisc-322 M-111 M-278 M-180 M-169 M-146 M-103 M-60 M-48 M117 M
Othincexp3 M-2 M-7 M-231000.0-1 M15 M18 M23 M17 M5 M
Pretaxinc-321 M-376 M-331 M-180 M-189 M-146 M-102 M-58 M-58 M105 M
Resdev217 M245 M227 M210 M229 M141 M124 M78 M71 M50 M
Restruct2 M11 M-242000.04 M893000.0
Sga264 M266 M198 M150 M136 M129 M104 M101 M92 M80 M
Shsout89 M76 M65 M63 M60 M43 M41 M40 M38 M37 M
Specincchg-2 M-11 M-25 M242000.0-6 M-6 M11 M
Taxprov120000.0223000.0313000.0409000.0-19 M-21000.0811000.01 M-10 M-12 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader